Category Archives: Advocacy & Partnerships

Federal funding for Palliative Care

On May 10, 2019, federal Health Minister Ginette Petitpas Taylor announced funding to help strengthen palliative care in Canada.  (View press release here).

Three national organizations will receive more than $4.5 million in funding:

  • $1.9 million over three years to the Canadian Hospice Palliative Care Association to help Canadians prepare for their future health care needs, including through public education and awareness, community workshops, and a renewed strategy to promote advance care planning.
  • $2 million over three years to the Canadian Virtual Hospice to expand existing virtual services and resources for palliative care and grief support to meet the needs of underserved communities, including families caring for a dying child, Francophones, and LGBTQ2 communities.
  • $600,000 over two years to the Canadian Home Care Association to help improve delivery of palliative care at home and communication with patients, families, and caregivers.


Thank you to the Ministry of Health for supporting this important work — and congratulations to the recipients!

Joint Letter in Support of Dan’s Law

(March 2019) The CSPCP joined ten other organizations in a letter to thank Ontario Minister of Health and Long Term Care, Christine Elliott, for her support of Dan’s Law (Bill 73) in Ontario.

The original bill, Dan’s Law, was a joint effort of MPP Lisa Gretzky and Dr. Darren Cargill, a palliative care physician in Windsor. The goal is to remove the three-month waiting period for OHIP funded palliative care and home care for Canadian residents who move to or return to Ontario. If the Bill passes, it will help many patients and families, and it could set a precedent for other provinces that have waiting periods. The Bill has passed First Reading.

Link to letter:Read More
Link to Bill 73: https://www.ola.org/en/legislative-business/bills/parliament-42/session-1/bill-73

CSPCP and CHPCA request exception to new standards from NAPRA

(March 4, 2019) Recently-released Model Standards for Pharmacy Compounding for Non-Hazardous Sterile Preparations from the National Association of Pharmacy Regulatory Authorities (NAPRA) stipulate that community pharmacies must use a Before Use Date of twelve hours for pre-filled medication syringes. This significantly affects our ability to provide care for patients with palliative care needs in the home, especially at end of life.

The CSPCP and Canadian Hospice Palliative Care Association jointly wrote to NAPRA on February 19, 2019, requesting an exception to this standard for palliative care. The letter describes the reasons why care is affected and what the impact is for patients, caregivers, and health care providers. Copies of the letter were sent to Health Canada, to their federal/provincial/territorial/palliative care group, and to the heads of the provincial Sections of Palliative Medicine. We are currently awaiting a response and will provide updates when available.

Read the letter

National Framework Implementation

Representatives from the Palliative 4 Canadians (P4C) group met with Health Canada on January 30, 2019 to begin discussing implementation of the national Framework on Palliative Care in Canada. The Framework was tabled in parliament on December 4, 2018 by the Honourable Ginette Petitpas Taylor, federal Minister of Health, after a year-long consultation with many stakeholders including the CSPCP. Health Canada reported that they will now develop a Framework implementation plan that aims to action the guiding principles and goals reflected in the Framework. Their goal is to have the plan ready by late Spring 2019. Health Canada also plans to establish an Office of Palliative Care to provide high level coordination of palliative care activities going forward. P4C shared suggestions on how the Office could be structured to optimize efficiency and results.

We look forward to seeing how the implementation unfolds and the CSPCP will continue to be an active partner. It is heartening to have federal politicians and Health Canada assist all of us with improving palliative care for all Canadians.

*Canada’s four national palliative care organizations – CSPCP, CHPCA, Canadian Virtual Hospice and Pallium Canada

CSPCP DEFENDS AVAILABILITY OF HIGH STRENGTH OPIOID FORMULATIONS FOR PALLIATIVE CARE

(Dec 7, 2018) The CSPCP responded to a commentary in the CMAJ asking for a ministerial recall of high-strength opioid formulations. Thank you to CSPCP Communications Committee Member Catriona Aparicio for helping prepare the response.

CSPCP response: http://www.cmaj.ca/content/190/48/E1404/tab-e-letters#cspcp-response-to-herder–juurlinks-high-strength-opioid-formulations-the-case-for-a-ministerial-recall